1. Home
  2. FINV vs WVE Comparison

FINV vs WVE Comparison

Compare FINV & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FinVolution Group

FINV

FinVolution Group

N/A

Current Price

$2.95

Market Cap

668.1M

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.37

Market Cap

673.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FINV
WVE
Founded
2007
2012
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
668.1M
673.9M
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
FINV
WVE
Price
$2.95
$3.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
21
Target Price
$5.62
★ $17.05
AVG Volume (30 Days)
866.5K
★ 2.9M
Earning Date
11-18-2026
10-27-2026
Dividend Yield
★ 10.55%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $3,704,000.00
Revenue This Year
N/A
$48.79
Revenue Next Year
N/A
N/A
P/E Ratio
$3.87
★ N/A
Revenue Growth
N/A
★ 149.43
52 Week Low
$2.80
$3.04
52 Week High
$6.39
$21.73

Technical Indicators

Market Signals
Indicator
FINV
WVE
Relative Strength Index (RSI) 47.43 43.99
Support Level $2.89 $3.04
Resistance Level $3.25 $3.97
Average True Range (ATR) 0.15 0.24
MACD 0.02 0.05
Stochastic Oscillator 59.02 35.14

Price Performance

Historical Comparison
FINV
WVE

About FINV FinVolution Group

FinVolution Group is a provider of online consumer finance in China. The company offers various loan products, making financial services available to borrowers anytime, anywhere; designs a loan transaction process, and offers tailored risk-based pricing. It offers short-term loans to borrowers to meet immediate credit needs while allowing them to gradually establish their credit history through activities on the company's platform. The company generates revenues from fees charged to borrowers. The Group's long-lived assets are located in the PRC, and its revenues are derived from within the PRC.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: